Scientists reprogram Patients' own cells to hunt prostate cancer
NCT ID NCT01140373
Summary
This early-stage study tests whether modified immune cells can safely fight advanced prostate cancer. Doctors take a patient's own T-cells, genetically alter them in a lab to better recognize cancer, then return them to the body. The goal is to see if these reprogrammed cells can attack prostate cancer tumors while being safe enough for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.